The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.
Fresno, California 93720, United States
Orthopedic Associates of Hartford
Hartford, Connecticut 06102, United States
Yale Center for Clinical Investigation, Yale School of Medicine
New Haven, Connecticut 06519, United States
Minimally Invasive Spine Center of South Florida
Miami, Florida 33133, United States
Foundation for Orthopaedic Research and Education
Tampa, Florida 33607, United States
Northeast Georgia Medical Center
Gainesville, Georgia 30501, United States
Carle Foundation Hospital, NeuroScience Institute
Urbana, Illinois 61801, United States
OrthoBethesda Research Foundation
Bethesda, Maryland 20817, United States
The patient is ≥21 years old.
The patient is, in the investigator's opinion, psychosocially, mentally, and physically able to fully comply with this protocol, including the post-operative regimen, required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent
The patient is willing and able to participate in post- operative clinical and radiographic follow up evaluations for 2 years.
Patients not meeting all of the inclusion criteria
Study Contact Info
Contact Listings Owner Form
OssDsign® Spine Registry Study (“Propel”) 0 reviewsWrite Your Review
There are no reviews yet.